Inflammatory Molecules Facilitate the Development of Docetaxel-Resistant Prostate Cancer Cells In Vitro and In Vivo

The changes in gene expression profiles of multidrug resistant prostate cancer cells that were established in response to docetaxel were determined using microarray analysis.